tiprankstipranks
Trending News
More News >
National Healthcare Corp. (NHC)
XASE:NHC
US Market

National Healthcare (NHC) Ratios

Compare
133 Followers

National Healthcare Ratios

NHC's free cash flow for Q3 2025 was $―. For the 2025 fiscal year, NHC's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.72 1.89 1.79 1.62 1.62
Quick Ratio
1.69 1.86 1.75 1.59 1.59
Cash Ratio
0.41 0.50 0.30 0.41 0.52
Solvency Ratio
0.28 0.27 0.16 0.36 0.15
Operating Cash Flow Ratio
0.55 0.52 0.04 0.24 0.72
Short-Term Operating Cash Flow Coverage
19.88 0.00 0.26 1.93 6.80
Net Current Asset Value
$ -73.61M$ 5.92M$ -44.00M$ -73.75M$ -110.20M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.07 0.10 0.12 0.14
Debt-to-Equity Ratio
0.17 0.10 0.14 0.18 0.24
Debt-to-Capital Ratio
0.14 0.09 0.13 0.16 0.20
Long-Term Debt-to-Capital Ratio
0.09 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.53 1.44 1.46 1.55 1.71
Debt Service Coverage Ratio
11.06 332.24 1.76 5.45 2.73
Interest Coverage Ratio
18.15 176.34 56.65 60.27 34.42
Debt to Market Cap
0.06 0.00 0.04 0.03 0.03
Interest Debt Per Share
11.56 6.12 8.21 10.91 12.77
Net Debt to EBITDA
0.33 -0.10 0.99 0.31 0.49
Profitability Margins
Gross Profit Margin
38.16%37.60%36.13%34.11%37.87%
EBIT Margin
9.77%7.80%2.59%14.92%5.49%
EBITDA Margin
12.79%11.48%6.36%18.95%9.77%
Operating Profit Margin
7.72%5.00%2.97%5.04%4.91%
Pretax Profit Margin
9.61%7.77%2.53%14.84%5.35%
Net Profit Margin
7.20%5.85%2.09%13.71%4.27%
Continuous Operations Profit Margin
7.22%5.72%1.86%13.76%4.28%
Net Income Per EBT
74.86%75.28%82.42%92.37%79.87%
EBT Per EBIT
124.47%155.32%85.37%294.63%108.86%
Return on Assets (ROA)
6.71%5.10%1.76%9.88%3.07%
Return on Equity (ROE)
10.50%7.35%2.57%15.35%5.27%
Return on Capital Employed (ROCE)
8.70%5.21%2.96%4.47%4.46%
Return on Invested Capital (ROIC)
6.33%3.73%2.04%3.92%3.38%
Return on Tangible Assets
7.64%5.88%2.04%11.29%3.12%
Earnings Yield
5.29%4.72%2.45%13.29%4.12%
Efficiency Ratios
Receivables Turnover
10.25 10.47 10.71 10.47 10.82
Payables Turnover
42.41 37.11 40.46 29.62 28.86
Inventory Turnover
114.34 96.45 96.81 77.61 69.39
Fixed Asset Turnover
1.97 1.94 1.71 1.94 1.88
Asset Turnover
0.93 0.87 0.84 0.72 0.72
Working Capital Turnover Ratio
7.10 6.56 6.73 5.96 6.09
Cash Conversion Cycle
30.19 28.82 28.82 27.25 26.33
Days of Sales Outstanding
35.60 34.87 34.07 34.87 33.72
Days of Inventory Outstanding
3.19 3.78 3.77 4.70 5.26
Days of Payables Outstanding
8.61 9.83 9.02 12.32 12.65
Operating Cycle
38.80 38.65 37.84 39.57 38.98
Cash Flow Ratios
Operating Cash Flow Per Share
9.64 7.26 0.57 4.07 13.28
Free Cash Flow Per Share
7.69 5.44 -1.39 1.50 11.85
CapEx Per Share
1.95 1.82 1.96 2.57 1.43
Free Cash Flow to Operating Cash Flow
0.80 0.75 -2.45 0.37 0.89
Dividend Paid and CapEx Coverage Ratio
2.20 1.75 0.13 0.87 3.78
Capital Expenditure Coverage Ratio
4.94 3.99 0.29 1.58 9.29
Operating Cash Flow Coverage Ratio
0.86 1.19 0.07 0.37 1.05
Operating Cash Flow to Sales Ratio
0.10 0.10 <0.01 0.06 0.21
Free Cash Flow Yield
5.98%5.89%-2.34%2.21%17.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.67 21.18 40.85 7.52 24.28
Price-to-Sales (P/S) Ratio
1.35 1.24 0.85 1.03 1.04
Price-to-Book (P/B) Ratio
1.91 1.56 1.05 1.15 1.28
Price-to-Free Cash Flow (P/FCF) Ratio
16.51 16.98 -42.73 45.34 5.60
Price-to-Operating Cash Flow Ratio
13.12 12.72 104.89 16.71 5.00
Price-to-Earnings Growth (PEG) Ratio
-6.22 0.11 -0.49 0.03 -0.63
Price-to-Fair Value
1.91 1.56 1.05 1.15 1.28
Enterprise Value Multiple
10.87 10.69 14.41 5.75 11.10
Enterprise Value
2.05B 1.40B 984.18M 1.10B 1.06B
EV to EBITDA
11.00 10.69 14.41 5.75 11.10
EV to Sales
1.41 1.23 0.92 1.09 1.08
EV to Free Cash Flow
17.23 16.82 -45.87 47.91 5.86
EV to Operating Cash Flow
13.75 12.60 112.58 17.66 5.23
Tangible Book Value Per Share
54.01 48.02 45.57 47.41 50.56
Shareholders’ Equity Per Share
66.09 59.36 56.73 58.84 51.95
Tax and Other Ratios
Effective Tax Rate
0.25 0.26 0.27 0.07 0.20
Revenue Per Share
94.19 74.56 69.71 65.87 64.07
Net Income Per Share
6.78 4.36 1.46 9.03 2.74
Tax Burden
0.75 0.75 0.82 0.92 0.80
Interest Burden
0.98 1.00 0.98 0.99 0.97
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.04 0.04 0.04 0.04 0.04
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.41 1.66 0.44 0.45 4.84
Currency in USD